Shanghai Jiuchuan, a privately held investment company with diversified holdings, including ownership of more than 3,000 hospitals in China, acquired SHL Telemedicine for approximately $130 Million. SHL develops personal telemedicine systems and medical call center services, with a focus on cardiovascular and related diseases, for end users and the healthcare community.
Meitar represented Viola Group, Hans Wagner and Sariel Engel in a $24M investment in VATBox, a SaaS provider of automated VAT recovery and governance solutions.
A fascinating article published in “TheMarker” magazine by Eldar Ben-Ruby, Meitar’s Tax Practice Leader, takes a different angle on Israel’s potential imposition of inheritance tax in terms of effectiveness, lack of moral justification and international implications, and offers alternative ways of using the existing tax system to promote distributive justice in Israeli society.
For the full article published at “TheMarker” (Hebrew),
Meitar represented Lumenis, a global leader in the field of minimally-invasive clinical solutions for the surgical, ophthalmology and aesthetic markets, in its acquisition by XIO Group, a Chinese private equity fund, for approximately $510 million.
Meitar represented Emerson, a diversified global manufacturing company listed on the NYSE with a market value of $37 billion, in its acquisition of Spectronix, a public company listed on the TASE which develops advanced flame and gas detectors for the military and civilian industries, for $99 million.
Meitar represented Infinidat, a leading company engaged in information storage, in its $150 million investment round led by TPG Capital Fund, at a company value of over $1 billion.
Foreign investments in China are facing revolutionary reforms, as described in a recent article published by Yoav Sade, head of Meitar’s China practice and Jianjian Gong (a PRC attorney at Meitar’s China practice), in TheMarker magazine.
For the full article published (Hebrew), למידע נוסף לחץ כא
